Tag Archives: CDSCO

Bharat Biotech vaccine candidate approved for use in clinical trial mode. The first COVID-19 vaccine developed in India, Covaxin, has been recommended for “restricted use in emergency situations, subject to multiple regulatory conditions” by the Subject Matter Expert Committee (SEC) of the Central Medicines Control Organization ( CDSCO), here on …

Covaxin has been indigenously developed in collaboration with ICMR. An expert panel from India’s central drug authority recommended on January 2 to grant permission for the emergency restricted use of the locally developed COVID-19 vaccine Covaxin with certain conditions, a day after giving similar instructions for the COVID vaccine. -19 …

NEW DELHI: A committee of experts from the Central Drug Standard Control Organization (CDSCO) on Wednesday sought additional safety and efficacy data for Covid-19 vaccine candidates from Serum Institute and Bharat Biotech, after deliberating on their applications to obtain an emergency use authorization for injections. official sources said. The request …

A committee of experts from the Central Standard Medicines Control Organization (CDSCO) will meet on Wednesday to review applications from Pfizer, Serum Institute of India and Bharat Biotech seeking emergency use authorization for their Covid-19 vaccine candidates. official sources said Monday night. The decision was made late Monday night after …

NEW DELHI: Taking as a reference the benchmarks set by the World Health Organization and the US Food and Drug Administration, India’s drug regulator has said that it plans to approve the covid-19 vaccines that can provide immunity to at least 50% of the participants in phase 3 clinical trials. …

If advanced clinical trials of the Covid-19 vaccine are successful, an effective vaccine will likely be available by the end of the first quarter of 2021, State Health Minister Ashwini Choubey informed Lok Sabha on Friday. I was answering a question about when an effective Covid-19 vaccine is likely to …